An additional 53 cases of COVID-19 have been identified in B.C. over the past 48 hours.
A total of 2,224 people have been infected in the province and 1,417 of those people are now fully recovered.
By health authority, there have been 1,027 cases in Fraser Health, 845 cases in Vancouver Coastal, 177 in Interior (up three from Saturday), 124 in Island and 51 in Northern.
There are 77 COVID-19 patients in B.C. hospitals, 20 of whom are in intensive-care units.
Three more people have died in the last 24 hours from COVID-19, all of whom were residents at long-term care homes in the Lower Mainland, bringing the province’s COVID-19 death toll to 117. Two of those deaths occurred in Interior Health, with a man in Kelowna and a man in Royal Inland Hospital in Kamloops succumbing to the disease.
There are 21 active outbreaks at long-term care homes and assisted living facilities, and two outbreaks at hospital acute-care units, with 266 residents and 168 staff affected, Provincial Health Officer Dr. Bonnie Henry said.
There are no new cases as of Monday at any of the impacted facilities, which are predominantly located in theVancouver Coastal and Fraser Health regions.
One care home in Kelowna currently has an outbreak of COVID-19.
Three COVID-19 outbreaks remain at poultry farms in the Lower Mainland, totalling 96 cases.
Henry said there are 54 cases at Superior Poultry, 35 cases at United Poultry and seven cases at Fraser Valley Specialty Poultry.
There are also 134 cases of COVID-19 at the federal penitentiary in Mission, where 121 inmates and 13 staff have been infected. One inmate has died.
There have been
Henry said there are now 15 people in B.C. who returned from the Kearl Lake oil sands project in northern Alberta and tested positive for COVID-19. There have also been additional family members of those people who have contracted the virus. Interior Health has 12 confirmed cases among workers from Kearl Lake, as well as seven confirmed cases of people who did not travel to Kearl Lake, but had contact with a worker. Of these 19 cases, 16 people have recovered.
“This is one of the reasons we have been so concerned,” Henry said.
Anyone returning from working in Kearl Lake is asked to self-isolate and close contacts such as family members should monitor for symptoms until the outbreak there is declared over.
Henry said she is aware of one instance in which someone returned from Kearl Lake didn’t recognize they had a mild illness of COVID-19 and passed it on to a close contact who was a health-care worker.
“We need to be very vigilant right now,” Henry said.
Public health working to contain latest COVID-19 outbreaks – WellandTribune.ca
'No benefit' from hydroxychloroquine for virus: UK trial – The Jakarta Post – Jakarta Post
A major British clinical trial has found hydroxychloroquine has “no benefit” for patients hospitalized with COVID-19, scientists said Friday, in the first large-scale study to provide results for a drug at the center of political and scientific controversy.
Hydroxychloroquine, a decades-old malaria and rheumatoid arthritis drug, has been touted as a possible treatment for the new coronavirus by high profile figures, including US President Donald Trump, and has been included in several randomized clinical trials.
The University of Oxford’s Recovery trial, the biggest of these so far to come forward with findings, said that it would now stop recruiting patients to be given hydroxychloroquine “with immediate effect”.
“Our conclusion is that this treatment does not reduce the risk of dying from COVID among hospital patients and that clearly has a significant importance for the way patients are treated, not only in the UK, but all around the world,” said Martin Landray, an Oxford professor of medicine and epidemiology who co-leads the study.
The randomized clinical trial—considered the gold standard for clinical investigation—has recruited a total of 11,000 patients from 175 hospitals in the UK to test a range of potential treatments.
Other drugs continuing to be tested include: the combination of HIV antivirals Lopinavir and Ritonavir; a low dose of the steroid Dexamethasone, typically used to reduce inflammation; antibiotic Azithromycin; and the anti inflammatory drug Tocilizumab.
Researchers are also testing convalescent plasma from the blood of people who have recovered from COVID-19, which contains antibodies to fight the virus.
Researchers said 1,542 patients were randomly assigned to hydroxychloroquine and compared with 3,132 patients given standard hospital care alone.
They found “no significant difference” in mortality after 28 days between the two groups, and no evidence that treatment with the drug shortens the amount of time spent in hospital.
“This is a really important result, at last providing unequivocal evidence that hydroxychloroquine is of no value in treatment of patients hospitalized with COVID-19,” said Peter Openshaw, a professor at Imperial College London, in reaction to the results.
He added that the drug was “quite toxic” so halting the trials would be of benefit to patients.
Hydroxychloroquine has been in use for years but it has a number of potentially serious side effects, including heart arrhythmia.
Researchers from the Recovery trial said they would share their data with the World Health Organization (WHO), which on Wednesday restarted its own trials of hydroxychloroquine.
They were temporarily halted last month because of a now-retracted observational study in The Lancet medical journal that had suggested hydroxychloroquine and chloroquine, a related compound, were ineffective against COVID-19 and even increased the risk of death.
Authors of The Lancet research said on Thursday that they could no longer vouch for the integrity of its underlying data, in the face of serious concerns raised by fellow scientists over a lack of clarity about the countries and hospitals that contributed patient information.
The scandal cast a shadow over The Lancet and another top medical journal, but it did nothing to clear up the increasingly politicized question of whether or not hydroxychloroquine works as a treatment for COVID-19.
Openshaw said the Recovery trial should be credited with continuing the research until they could reach a definitive conclusion on hydroxychloroquine.
“Everyone regrets that it doesn’t work, but knowing that allows us to focus on finding drugs that actually help recovery from COVID-19,” he added.
Oxford professor Peter Horby, the lead investigator on the Recovery Trial, said there was probably a “very large number” of people around the world taking hydroxychloroquine for COVID-19, with countries including the US, China and Brazil authorizing it.
A separate clinical trial on Wednesday in the US and Canada found that taking hydroxychloroquine shortly after being exposed to COVID-19 does not work to prevent infection significantly better than a placebo.
If you want to help in the fight against COVID-19, we have compiled an up-to-date list of community initiatives designed to aid medical workers and low-income people in this article. Link: [UPDATED] Anti-COVID-19 initiatives: Helping Indonesia fight the outbreak
No new coronavirus cases in Manitoba on Saturday – Globalnews.ca
Manitoba health officials say there are no new cases of the coronavirus identified as of Saturday morning.
Health officials say the total number of lab-confirmed positive and probable cases in the province remains at 300.
There are nine active cases as of Friday and 284 individuals who have recovered from COVID-19.
The number of deaths due to COVID-19 remains at seven.
© 2020 Global News, a division of Corus Entertainment Inc.
McGregor retires from fighting – TSN
Public health working to contain latest COVID-19 outbreaks – WellandTribune.ca
Small asteroid to safely fly by Earth on Saturday – SHINE
- Tech10 hours ago
New release date for Call of Duty: Modern Warfare Season 4 has been leaked – PCGamesN
- Sports18 hours ago
Donald Trump says Drew Brees shouldn't have backed off flag comments – CBC.ca
- Tech17 hours ago
iOS 14 roundup: What we know before WWDC 2020 – 9to5Mac
- Economy9 hours ago
Guardians of the World Economy Stagger From Rescue to Recovery – Yahoo Canada Finance
- Tech24 hours ago
New Redmi 9 alleged prices are ridiculously cheap for a smartphone with a quad-camera setup and 8-core MediaTek Helio G80 SoC – Notebookcheck.net
- Economy21 hours ago
Don’t Lose the Thread. The Economy Is Experiencing an Epic Collapse of Demand. – The New York Times
- Tech23 hours ago
Apple iOS 13.5.5 Can’t Come Soon Enough: Here Are 3 Reasons Why – Forbes
- Tech2 hours ago
Call of Duty Modern Warfare Season 4 release: Is this when Warzone Season 4 comes out? – Express